Retinitis pigmentosa stem cell study tops ARVO news
Click Here to Manage Email Alerts
The annual Association for Research in Vision and Ophthalmology meeting was held in Vancouver, British Columbia, from April 28 to May 2.
Here are the top five stories and videos from Healio.com/OSN’s coverage of the meeting:
Phase 2a study shows improved vision with stem cell therapy for retinitis pigmentosa
Human retinal progenitor cell therapy from ReNeuron Group is showing positive preliminary results in the company’s ongoing phase 1/2a clinical trial involving patients with retinitis pigmentosa. Read more.
Most weight loss strategies associated with increased risk of glaucoma
Eating less was the only weight loss strategy found to decrease the odds of developing glaucoma, according to a poster. Read more.
Roche-Genentech sees future for AI in retinal disease prevention
Executives and researchers shared their vision at a company-sponsored event for the potential of using technology for not only personalized treatment but disease prevention. Read more.
VIDEO: Wet AMD gene therapy trial shows optimistic results
Allen C. Ho, MD, of Wills Eye Hospital discusses phase 1/2 data from a clinical trial of a gene therapy treatment candidate for wet age-related macular degeneration. Watch here.
Retinal changes may reflect dementia progression
Results of a cross-sectional prospective study showed that several retinal changes were associated with both posterior cortical atrophy and typical Alzheimer’s disease. Read more.